---
layout: default
title: About
permalink: /about3
---

# About

PD2AF converter is an open-source application designed to enable communication between the Process Description and the Activity Flow languages of the SBGN standard. The converter uses the concept of the SBGN Bricks and additionally detects advanced network patterns such as, for example, "hidden" inhibition, when the mechanism of inhibition is shown in details and no inhibition arcs are used.  



## Availability

The tools is in development. The code is available at [https://github.com/pd2af](https://github.com/pd2af).

<!--
## Availability
The code is available at [https://github.com/pd2af](https://github.com/pd2af). 
Online conversion (experimental version): [http://pd2af.me](http://pd2af.me/)   
Converter engine: [https://github.com/pd2af/converter](https://github.com/pd2af/converter)  
-->

## Contact

To contribute and discuss the project please use this email address: [pd2af@googlegroups.com](mailto:pd2af@googlegroups.com)  
Lead developer: Denis Shirshov [denis.shirshov@gmail.com](mailto:denis.shirshov@gmail.com)  
PD2AF project coordinator: Alexander Mazein [a.mazein@gmail.com](mailto:a.mazein@gmail.com) 

## Project Team

<table>
<tr>
<td style="width: 200px;"><p style="margin:4px;"><img src="/images/team/DenisShirshov.jpg" width="160"/></p></td>
<td style="width: 200px;"><p style="margin:4px;"><img src="/images/team/AlexanderMazein.jpg" width="160"/></p></td>
<td style="width: 200px;"><p style="margin:4px;"><img src="/images/team/AdrienRougny.jpg" width="160"/></p></td>
<td style="width: 200px;"><p style="margin:4px;"><img src="/images/team/AnatolySorokin.jpg" width="160"/></p></td>
</tr>
</table>

<table>
<tr>
<td style="width: 200px;"><p style="margin:4px;"><strong>Denis Shirshov</strong></p><p style="margin:4px; line-height:100%;"><font size="2">European Institute for Systems Biology and Medicine, Lyon, France</font></p></td>
<td style="width: 200px;"><p style="margin:4px;"><strong>Alexander Mazein</strong></p><p style="margin:4px; line-height:100%;"><font size="2">Luxembourg Centre for Systems Biomedicine, University of Luxembourg, Belval, Luxembourg</font></p></td>
<td style="width: 200px;"><p style="margin:4px;"><strong>Adrien Rougny</strong></p><p style="margin:4px; line-height:100%;"><font size="2">National Institute of Advanced Industrial Science and Technology, Tokyo, Japan</font></p></td>
<td style="width: 200px;"><p style="margin:4px;"><strong>Anatoly Sorokin</strong></p><p style="margin:4px; line-height:100%;"><font size="2">Institute of Cell Biophysics, Russian Academy of Science, Pushchino, Russia</font></p></td>
</tr>
</table>


<table>
<tr>
<td style="width: 200px;"><p style="margin:4px;"><br /><img src="/images/team/VasundraToure.jpg" width="160"/></p></td>
<td style="width: 200px;"><p style="margin:4px;"><br /><img src="/images/team/IrinaBalaur.jpg" width="160"/></p></td>
<td style="width: 200px;"><p style="margin:4px;"><br /><img src="/images/team/JohannPellet.jpg" width="160"/></p></td>
<td style="width: 200px;"><p style="margin:4px;"><br /><img src="/images/team/CharlesAuffray.jpg" width="160"/></p></td>
</tr>
</table>

<table>
<tr>
<td style="width: 200px;"><p style="margin:4px;"><strong>Vasundra Toure</strong></p><p style="margin:4px; line-height:100%;"><font size="2">Norwegian University of Science and Technology, Trondheim, Norway</font></p></td>
<td style="width: 200px;"><p style="margin:4px;"><strong>Irina Balaur</strong></p><p style="margin:4px; line-height:100%;"><font size="2">European Institute for Systems Biology and Medicine, Lyon, France</font></p></td>
<td style="width: 200px;"><p style="margin:4px;"><strong>Johann Pellet</strong></p><p style="margin:4px; line-height:100%;"><font size="2">European Institute for Systems Biology and Medicine, Lyon, France</font></p></td>
<td style="width: 200px;"><p style="margin:4px;"><strong>Charles Auffray</strong></p><p style="margin:4px; line-height:100%;"><font size="2">European Institute for Systems Biology and Medicine, Lyon, France</font></p></td>
</tr>
</table>

## Funding

This work was supported in part by the Innovative Medicines Initiative Joint Undertaking under grant agreement no. IMI 115446 (eTRIKS), resources of which are composed of financial contribution from the European Union's Seventh Framework Programme (FP7/2007-2013) and EFPIA companies.

## Acknowledgements

The PD2AF tool is built on and further develops the logic of the previously published template-based translation from PD to AF (Vogt et al., 2013, [doi:10.1186/1752-0509-7-115](https://doi.org/10.1186/1752-0509-7-115)) which is accessible as a functionality of the SBGN-ED add-on of the VANTED editor.


